| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 01/03/2012 | US8088917 Ionic liquids |
| 01/03/2012 | US8088817 Pyrrole derivative having, as substituents, ureido group, aminocarbonly group and bicyclic group which may have substituent |
| 01/03/2012 | US8088808 Substituted N-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 01/03/2012 | US8088802 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
| 01/03/2012 | US8088800 4-(5-aminomethyl)-indole-1-ylmethyl)-benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity |
| 01/03/2012 | US8088776 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 01/03/2012 | US8088771 Cycloalkylidene and heterocycloalkylidene inhibitor compounds |
| 01/03/2012 | US8088769 e.g. 2-(3,4-Dichlorophenyl)ethanamidine hydrochloride; phosphodiesterases inhibitor; learning enhancement, cognition activator; improving perception, concentration, or memory |
| 01/03/2012 | US8088766 Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors |
| 01/03/2012 | CA2667566C Pyrazole analogs |
| 01/03/2012 | CA2629092C Process for the manufacture of epoxybutanol intermediates |
| 01/03/2012 | CA2528656C 5ht4-antagonistic 4-(aminomethyl)-piperidine benzamides |
| 01/03/2012 | CA2494183C Processes for preparing 1,3-dioxolane nucleosides |
| 01/03/2012 | CA2480356C Benzamide derivatives useful as histone deacetylase inhibitors |
| 01/03/2012 | CA2456717C Phenyl derivatives as factor xa inhibitors |
| 12/29/2011 | WO2011163610A2 Antimicrobial agents |
| 12/29/2011 | WO2011162562A2 [6+5] fused bicycles as a thrombin antagonist, process for preparation thereof and pharmaceutical compositions containing the bicycles |
| 12/29/2011 | WO2011162364A1 Noxious arthropod control composition, and heterocyclic compound |
| 12/29/2011 | WO2011162162A1 Light-emitting device material and light-emitting device |
| 12/29/2011 | WO2011161945A1 Alkoxyimino derivative and pest control agent |
| 12/29/2011 | WO2011161615A1 5-lipoxygenase inhibitors |
| 12/29/2011 | WO2011160594A1 New preparation method of lapatinib |
| 12/29/2011 | US20110319626 Use of Atorvastatin Lactols as Medicaments |
| 12/29/2011 | US20110319618 Heterocyclic compound and use of the same |
| 12/29/2011 | US20110319589 Long chain alkylene group-containing epoxy compound |
| 12/29/2011 | US20110319448 Guanidine-containing compounds useful as muscarinic receptor antagonists |
| 12/29/2011 | US20110319400 Prokineticin 1 receptor antagonists for the treatment of pain |
| 12/29/2011 | US20110318788 Multisignal labeling reagents and processes and uses therefor |
| 12/29/2011 | US20110318772 Reactive coumarin derivatives and their use in cellular analyses |
| 12/29/2011 | US20110318393 Substituted Pyrazole Compounds |
| 12/29/2011 | CA2803890A1 Antimicrobial agents |
| 12/28/2011 | EP2399925A1 Method for fluorescently labeling protein |
| 12/28/2011 | EP2399916A1 Process and intermediates for the preparation of aspartic acetal caspase ihnhibitors |
| 12/28/2011 | EP2399915A1 Process and intermediates for the preparation of aspartic acetal caspase inhibitors |
| 12/28/2011 | EP2399912A2 An exo-selective synthesis of himbacine analogs |
| 12/28/2011 | EP2399906A1 Aromatic amine derivative and organic electroluminescent element |
| 12/28/2011 | EP2399903A1 Ccr9 inhibitors and methods of use thereof |
| 12/28/2011 | EP2398793A1 Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators |
| 12/28/2011 | EP2398791A1 INDOLE/BENZIMIDAZOLE COMPOUNDS AS mTOR KINASE INHIBITORS |
| 12/28/2011 | EP2398771A2 Heterocyclic compounds which modulate the cb2 receptor |
| 12/28/2011 | EP2398769A1 Novel ortho-aminoamides for the treatment of cancer |
| 12/28/2011 | EP2398474A1 Inhibitors of hcv ns5a |
| 12/28/2011 | EP2398323A1 Novel hetero pyrrole analogs acting on cannapinoid receptors |
| 12/28/2011 | EP1981871B1 Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase |
| 12/28/2011 | EP1697348B1 Hiv protease inhibiting compounds |
| 12/28/2011 | EP1664036B1 Benzimidazolone compounds having 5-ht4 receptor agonistic activity |
| 12/28/2011 | EP1414456B1 Phenyl derivatives as factor xa inhibitors |
| 12/28/2011 | CN1930135B 作为P2X<sub>3</sub>和P2X<sub>2/3</sub>拮抗剂的二氨基嘧啶 As P2X <sub> 3 </ sub> and P2X <sub> 2/3 </ sub> antagonists diaminopyrimidines |
| 12/28/2011 | CN102300861A 包含磺酰胺基团的呫吨染料 Contains a sulfonamide group of xanthene dyes |
| 12/28/2011 | CN102300852A 杀真菌剂n-环烷基-n-双环亚甲基-羧酰胺衍生物 Fungicides n- cycloalkyl -n- bicyclic methylene - carboxamide derivatives |
| 12/28/2011 | CN102300845A 用于治疗癌症的新型邻氨基酰胺类 Anthranilic acid amides for the new cancer treatment |
| 12/28/2011 | CN102295639A 三(β-甲基环氧丙基)异氰尿酸酯的制备方法 Three (β- methyl-epoxypropyl) isocyanurate preparation |
| 12/28/2011 | CN102295638A 拉帕替尼的新制备方法 Lapatinib new preparation method |
| 12/28/2011 | CN102295637A 5-lipoxygenase-activating protein (FLAP) inhibitors |
| 12/28/2011 | CN102295636A 吲哚-3-基-羰基-哌啶和哌嗪衍生物 Indol-3-yl - carbonyl - piperidine and piperazine derivatives |
| 12/28/2011 | CN102295634A 新的羟基-6-杂芳基菲啶及其作为pde4抑制剂的用途 The new hydroxy-6-heteroaryl phenanthrene piperidine and its use as an inhibitor pde4 |
| 12/28/2011 | CN102295610A 1-芳基-2-（1,2,4-三唑-1-基）乙醇的制备方法与应用 1-aryl-2- (1,2,4-triazol-1-yl) ethanol Preparation and Application |
| 12/28/2011 | CN102295606A 合成3-（1，3-苯并间二氧杂环戊烯-5-基）-6-（4-环丙基哌嗪-1-基）-哒嗪的方法及其适用的中间体 Synthesis of 3- (1,3-benzodioxol-5-yl) -6- (4-cyclopropyl-piperazin-1-yl) - pyridazine method and suitable intermediates |
| 12/28/2011 | CN102295594A 4-n-取代-1-(3-甲氧基丙基)-4-哌啶胺类化合物及制备和应用 Substituted 4-n- -1- (3- methoxypropyl) -4-piperidinyl amine compound of Preparation and Applications |
| 12/28/2011 | CN101565413B 乙酰氨基酸苄酯修饰的异黄酮衍生物及其制备方法和应用 Acetyl amino acid benzyl ester modified isoflavone derivatives and preparation method and application |
| 12/28/2011 | CN101522667B 4-(n-甲基-2-氯-5-吡啶基甲基氨基)-2,5-二氢呋喃-2-酮的晶型 4- (n- methyl-2-chloro-5-pyridyl-methyl-amino) -2,5-dihydro-furan-2-one in crystalline form |
| 12/28/2011 | CN101415682B 被取代的烯氨羰基化合物 Substituted alkenyl aminocarbonyl compound |
| 12/28/2011 | CN101379034B 作为cetp抑制剂的苯甲酰胺和杂芳烃衍生物 As cetp inhibitors benzamide derivatives and heteroarene |
| 12/27/2011 | US8084609 Vasopressin receptor (V1a) antagonists, treatment of anxiety and depressive disorders and other diseases |
| 12/27/2011 | US8084457 Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases |
| 12/27/2011 | US8084456 Pyrazine-based tubulin inhibitors |
| 12/27/2011 | US8084450 Organic compounds |
| 12/27/2011 | US8084146 Light-emitting device material and light-emitting device |
| 12/22/2011 | WO2011159854A1 Cyclohexyl-azetidinyl antagonists of ccr2 |
| 12/22/2011 | WO2011159471A2 Linked purine pterin hppk inhibitors useful as antibacterial agents |
| 12/22/2011 | WO2011159302A1 Arylindenopyrimidines for treating neurodegenerative and movement disorders while minimizing cardiac toxicity |
| 12/22/2011 | WO2011158833A1 Agent for treating hcv infection |
| 12/22/2011 | WO2011158248A2 Process for preparation of posaconazole and crystalline polymorphic form v of posaconazole |
| 12/22/2011 | WO2011158149A1 2-(3,5-disubstitutedphenyl)pyrimidin-4(3h)-one derivatives |
| 12/22/2011 | WO2011157651A1 Anthranilic acid diamide derivatives with cyclical side chains |
| 12/22/2011 | WO2011156889A1 Novel modulators of nrf2 and uses thereof |
| 12/22/2011 | WO2011089623A3 Process for preparing pitavastatin and pharmaceutically acceptable salts thereof |
| 12/22/2011 | WO2010145764A8 Substituted enamino carbonyl compounds |
| 12/22/2011 | US20110313153 5-ht4 inhibitors for treating airway diseases, in particular asthma |
| 12/22/2011 | US20110313015 Fludioxonil Derivatives |
| 12/22/2011 | US20110313003 Gpr120 receptor agonists and uses thereof |
| 12/22/2011 | US20110313000 Ccr9 inhibitors and methods of use thereof |
| 12/22/2011 | US20110312996 Novel inhibitors of hepatitis c virus replication |
| 12/22/2011 | US20110312994 Biphenyl derivatives |
| 12/22/2011 | US20110312971 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 12/22/2011 | US20110312969 Compounds for treating cancer |
| 12/22/2011 | US20110312964 Cysteine protease inhibitors |
| 12/22/2011 | US20110312963 P38 map kinase inhibitors |
| 12/22/2011 | US20110312949 Pharmaceutical use of substituted amides |
| 12/22/2011 | US20110312944 Heterocyclic Compounds Which Modulate The CB2 Receptor |
| 12/22/2011 | US20110312936 Cyclohexyl-azetidinyl antagonists of ccr2 |
| 12/22/2011 | US20110312935 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents |
| 12/22/2011 | US20110312931 Glycine transporter-1 inhibitors, methods of making them, and uses thereof |
| 12/22/2011 | US20110312904 Compounds, compositions and methods for reducing toxicity and treating or preventing diseases |
| 12/22/2011 | US20110311516 Chemically Programmed Vaccination |
| 12/22/2011 | CA2802477A1 Agent for treating hcv infection |
| 12/22/2011 | CA2801934A1 Cyclohexyl-azetidinyl antagonists of ccr2 |
| 12/21/2011 | EP2397479A1 Hetero ring derivative |
| 12/21/2011 | EP2397476A2 Indole derivative having PGD2 receptor antagonist activity |
| 12/21/2011 | EP2397471A1 Benzimidazole compounds and their use |